Bell Graeme 4
4 · Intellia Therapeutics, Inc. · Filed Nov 3, 2017
Insider Transaction Report
Form 4
Bell Graeme
EVP, Chief Financial Officer
Transactions
- Award
Common Stock
2017-11-03$22.04/sh+5,000$110,217→ 13,400 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.85 to $22.15.